Group One Trading
CARM

Group One Trading’s Carisma Therapeutics CARM Stock Holding History

Group One Trading’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,230
Closed -$611 – 8200
2025
Q3 		$611 Hold
2,230
– – ﹤0.01% 8122
2025
Q2 		$873 Hold
2,230
– – ﹤0.01% 7591
2025
Q1 		$691 Hold
2,230
– – ﹤0.01% 7236
2024
Q4 		$934 Hold
2,230
– – ﹤0.01% 6904
2024
Q3 		$2.19K Hold
2,230
– – ﹤0.01% 6117
2024
Q2 		$3.39K Buy
2,230
+995
+81% +$1.48K ﹤0.01% 6101
2024
Q1 		$2.8K Sell
1,235
-7,555
-86% -$18.2K ﹤0.01% 6403
2023
Q4 		$25.8K Buy
8,790
+178
+2% +$529 ﹤0.01% 5556
2023
Q3 		$36.4K Buy
8,612
+1,257
+17% +$7.96K ﹤0.01% 5388
2023
Q2 		$64.5K Sell
7,355
-6,042
-45% -$32.9K ﹤0.01% 5046
2023
Q1 		$41.5K Sell
13,397
-3,946
-23% -$37.6K ﹤0.01% 4988
2022
Q4 		$211K Sell
17,343
-3,452
-17% -$36.3K ﹤0.01% 3819
2022
Q3 		$177K Buy
20,795
+3,008
+17% +$41K ﹤0.01% 4266
2022
Q2 		$288K Sell
17,787
-1,849
-9% -$21.2K ﹤0.01% 3943
2022
Q1 		$237K Sell
19,636
-19,668
-50% -$275K ﹤0.01% 4617
2021
Q4 		$641K Buy
39,304
+22,295
+131% +$449K ﹤0.01% 3839
2021
Q3 		$270K Buy
17,009
+11,193
+192% +$537K ﹤0.01% 4856
2021
Q2 		$537K Sell
5,816
-3,075
-35% -$196K ﹤0.01% 4148
2021
Q1 		$462K Buy
8,891
+6,078
+216% +$287K ﹤0.01% 4129
2020
Q4 		$76K Sell
2,813
-196
-7% -$4.97K ﹤0.01% 4759
2020
Q3 		$84K Buy
3,009
+2,953
+5,273% +$59.1K ﹤0.01% 4310
2020
Q2 		$1K Sell
56
-1,290
-96% -$17.4K ﹤0.01% 5628
2020
Q1 		$15K Buy
1,346
+33
+3% +$541 ﹤0.01% 4374
2019
Q4 		$27K Buy
1,313
+633
+93% +$14.5K ﹤0.01% 4257
2019
Q3 		$16K Sell
680
-152
-18% -$3.56K ﹤0.01% 4426
2019
Q2 		$25K Sell
832
-961
-54% -$28.8K ﹤0.01% 4069
2019
Q1 		$37K Sell
1,793
-910
-34% -$15.7K ﹤0.01% 3715
2018
Q4 		$77K Buy
+2,703
New +$86.2K ﹤0.01% 3323
2016
Q3 		– Sell
-30
Closed -$2.23K – 4558
2016
Q2 		$1K Sell
30
-90
-75% -$2.28K ﹤0.01% 4497
2016
Q1 		$1K Hold
120
– – ﹤0.01% 4434
2015
Q4 		$7K Buy
+120
New +$6.81K ﹤0.01% 4285

Other funds holding CARM

MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
EF
Empowered Funds Havertown, Pennsylvania $15.7B AUM 34.02% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
UBP
Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
OP
ORG Partners Roanoke, Indiana $568M AUM 24.16% 1-Year Est. Return

Group One Trading's CARM Position: Q4 2025 in Review

Group One Trading sold out of Carisma Therapeutics (CARM) in Q4 2025, closing a stake of 2,230 shares — an estimated $611 sold.

Group One Trading first reported a position in CARM in Q4 2015 and held it in 31 quarters. The position peaked at $641K in Q4 2021. 7 funds tracked by Wall St. Rank hold CARM as of Q4 2025.

  • Group One Trading reported no remaining Carisma Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 2,230 Carisma Therapeutics shares in Q4 2025, an estimated $611.
  • Group One Trading first reported a position in Carisma Therapeutics in Q4 2015 and held it in 31 quarters.
  • Group One Trading's Carisma Therapeutics position peaked at $641K in Q4 2021.
  • 7 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.